About Nova In Silico
Nova In Silico is a Healthcare company based in Lyon (France) founded in 2010 by Francois Henri Boissel. Developer of AI-driven in silico clinical trial platform for improving decision-making in biology, medicine, and data science. Its chief executive, as recorded, is Francois Henri Boissel. Nova In Silico offers products and services including jinkō Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials.
Company details
Nova In Silico was founded in 2010 in Lyon, France, as a developer of AI technologies focused on biology, medicine, and data science. The companys platform, Jinko, is utilized to simulate clinical trials through disease models and digital patient representations. Operations center on streamlining trial processes to support decision-making, with services provided in the biotech and AI sectors across Europe.
- Headquarters Lyon, France
- Founders Francois Henri Boissel
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website novainsilico.ai
- Social LinkedIn X YouTube
- Latest Funding Round$309.85K (USD), Grant
Sep 2015
Products & Services of Nova In Silico
Nova In Silico offers a comprehensive portfolio of products and services, including jinkō Platform.
Tool for predicting clinical trial outcomes using digital patients.
Apps and channels of Nova In Silico
its YouTube channel Nova In Silico has 62 subscribers and 30 videos.
Videos from Nova In Silico
The most watched videos on Nova In Silico's YouTube channel, Nova In Silico (62 subscribers). Click a video to play it here.
More on Nova In Silico.
Funding Insights of Nova In Silico
- Total Rounds 1
- Last Round Grant — $309,852
- First Round $309,852
(Sep 2015)
All 1 funding rounds of Nova In Silico with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2015 | $309,852 | Grant | – | – | – |
People of Nova In Silico
3 people are tracked at Nova In Silico (3 in leadership).
| Name | Role | Group |
|---|---|---|
Francois Henri Boissel | Co-Founder & CEO | Leadership |
Gregoire Boutonnet | Co-CEO | Leadership |
Frederic Cogny | Co-CEO | Leadership |
Complete people profiles for Nova In Silico
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nova In Silico
2 dated milestones of Nova In Silico across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Nova In Silico is founded.
- Funding First funding round of $310K.
Web traffic of Nova In Silico
The website of Nova In Silico (novainsilico.ai) receives about 4.8K visits a month.
- Monthly visits4.8K
▼ 6.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nova In Silico
Complete news archive for Nova In Silico
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nova In Silico
Nova In Silico was founded in 2010 and raised its 1st funding round 5 years after it was founded.
Nova In Silico is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Francois Henri Boissel is the CEO of Nova In Silico, as recorded in our data. They have also founded this company.
Nova In Silico was founded in 2010 in Lyon, France, as a developer of AI technologies focused on biology, medicine, and data science. The companys platform, Jinko, is utilized to simulate clinical trials through disease models and digital patient representations. Operations center on streamlining trial processes to support decision-making, with services provided in the biotech and AI sectors across Europe.
Nova In Silico offers jinkō Platform.